These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17383217

  • 1. MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent.
    Hess-Stumpp H, Bracker TU, Henderson D, Politz O.
    Int J Biochem Cell Biol; 2007; 39(7-8):1388-405. PubMed ID: 17383217
    [Abstract] [Full Text] [Related]

  • 2. HDAC inhibitors for the treatment of cancer.
    Secrist JP, Zhou X, Richon VM.
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127
    [Abstract] [Full Text] [Related]

  • 3. Development of histone deacetylase inhibitors for cancer treatment.
    Marchion D, Münster P.
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges.
    Atadja P.
    Cancer Lett; 2009 Aug 08; 280(2):233-41. PubMed ID: 19344997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S, Lauricella M, Tesoriere G.
    Int J Oncol; 2008 Oct 08; 33(4):637-46. PubMed ID: 18813776
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors for epigenetic therapy of cancer.
    Monneret C.
    Anticancer Drugs; 2007 Apr 08; 18(4):363-70. PubMed ID: 17351388
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL, Lee MY, Pui NN.
    Carcinogenesis; 2009 Aug 08; 30(8):1387-97. PubMed ID: 19351790
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M.
    Cancer Invest; 2006 Aug 08; 24(5):521-7. PubMed ID: 16939962
    [No Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors: development as cancer therapy.
    Marks PA, Richon VM, Kelly WK, Chiao JH, Miller T.
    Novartis Found Symp; 2004 Aug 08; 259():269-81; discussion 281-8. PubMed ID: 15171260
    [Abstract] [Full Text] [Related]

  • 16. Targeting epigenetic abnormalities with histone deacetylase inhibitors.
    Conley BA, Wright JJ, Kummar S.
    Cancer; 2006 Aug 15; 107(4):832-40. PubMed ID: 16826577
    [Abstract] [Full Text] [Related]

  • 17. HDAC inhibitors: clinical update and mechanism-based potential.
    Glaser KB.
    Biochem Pharmacol; 2007 Sep 01; 74(5):659-71. PubMed ID: 17498667
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylation as a target for radiosensitization.
    Cerna D, Camphausen K, Tofilon PJ.
    Curr Top Dev Biol; 2006 Sep 01; 73():173-204. PubMed ID: 16782459
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic regulation of airway inflammation.
    Adcock IM, Tsaprouni L, Bhavsar P, Ito K.
    Curr Opin Immunol; 2007 Dec 01; 19(6):694-700. PubMed ID: 17720468
    [Abstract] [Full Text] [Related]

  • 20. HDAC inhibitors: a potential new category of anti-tumor agents.
    Pan LN, Lu J, Huang B.
    Cell Mol Immunol; 2007 Oct 01; 4(5):337-43. PubMed ID: 17976313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.